Search

everythinglearnresearchcommunity

for

Search:↓

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

Activating Nrf2 in skin cells causes skin disease similar to chloracne in mice.

Overexpression of E2F1 can lead to skin tumors and disrupt hair growth.

Nfib in hair follicle stem cells boosts melanocyte stem cell growth and differentiation.

CSC is linked to mineralocorticoid receptor damage, stress, and steroid use, with treatments including drugs and laser therapies to prevent eye damage.

NDRG1 protein helps infantile hemangioma, a common infant tumor, to grow, and its mismanagement by FOXO1 protein plays a big role in causing the tumor.

Targeting NMMHC IIA may help treat blood-brain barrier damage.

Double-stranded RNA causes inflammation in hair follicle cells, which may help understand and treat alopecia areata.

Targeting impaired Nrf2 signaling might help treat hidradenitis suppurativa early on.

The Notch signaling pathway helps in mouse hair development through a noncanonical mechanism that does not rely on RBPj or transcription.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

LHX2 is essential for hair follicle development, controlled by NF-κB and TGFβ2 signaling.

17β-estradiol can reduce inflammation in the skin.

Blocking the NOTCH pathway can prevent fibrosis in systemic sclerosis.

NEDD4 and NEDD4L help control intestinal stem cells and prevent tumors by breaking down the LGR5 receptor.

A specific RNA, circNlgn, contributes to heart damage and scarring caused by the cancer drug doxorubicin.

p120-catenin helps control skin inflammation by regulating cadherin levels.

Blocking certain proteins can reduce skin inflammation caused by cancer treatment.

Blocking Wnt/β-catenin signaling with EGF receptor is necessary for proper hair growth.

ACKR2 helps prevent skin scarring and hair loss by controlling inflammation.

WNT10A and EBF1 interaction affects hair growth in male-pattern baldness.

ILC1-like cells can cause alopecia areata by themselves.

Targeting the TNFRSF1B gene may help treat hair loss.

Certain gene variations may increase the risk and severity of alopecia areata.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

Blocking a certain signal in the gp130 receptor can improve tissue healing and lessen osteoarthritis symptoms.

The Fas/FasL pathway may play a role in alopecia areata.

FER and TOR signaling help root hair growth in low temperature and low nitrate conditions.

Understanding how EDC genes are regulated can help develop better drugs for skin diseases.

FLCN helps control iron levels in cells.